Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386996839> ?p ?o ?g. }
- W4386996839 endingPage "6760" @default.
- W4386996839 startingPage "6760" @default.
- W4386996839 abstract "The therapeutic advantages of some platinum complexes as major anticancer chemotherapeutic agents and of nucleoside analogue-based compounds as essential antiviral/antitumor drugs are widely recognized. Red blood cells (RBCs) offer a potential new strategy for the targeted release of therapeutic agents due to their biocompatibility, which can protect loaded drugs from inactivation in the blood, thus improving biodistribution. In this study, we evaluated the feasibility of loading model nucleobase-containing Pt(II) complexes into human RBCs that were highly stabilized by four N-donors and susceptible to further modification for possible antitumor/antiviral applications. Specifically, platinum-based nucleoside derivatives [PtII(dien)(N7-Guo)]2+, [PtII(dien)(N7-dGuo)]2+, and [PtII(dien)(N7-dGTP)] (dien = diethylenetriamine; Guo = guanosine; dGuo = 2'-deoxy-guanosine; dGTP = 5'-(2'-deoxy)-guanosine-triphosphate) were investigated. These Pt(II) complexes were demonstrated to be stable species suitable for incorporation into RBCs. This result opens avenues for the possible incorporation of other metalated nucleobases analogues, with potential antitumor and/or antiviral activity, into RBCs." @default.
- W4386996839 created "2023-09-25" @default.
- W4386996839 creator A5009329347 @default.
- W4386996839 creator A5024925394 @default.
- W4386996839 creator A5025177419 @default.
- W4386996839 creator A5032278474 @default.
- W4386996839 creator A5041978951 @default.
- W4386996839 creator A5056143507 @default.
- W4386996839 creator A5057720777 @default.
- W4386996839 creator A5059500972 @default.
- W4386996839 creator A5065047824 @default.
- W4386996839 creator A5078664682 @default.
- W4386996839 creator A5082368537 @default.
- W4386996839 date "2023-09-22" @default.
- W4386996839 modified "2023-10-18" @default.
- W4386996839 title "Compatibility of Nucleobases Containing Pt(II) Complexes with Red Blood Cells for Possible Drug Delivery Applications" @default.
- W4386996839 cites W142990961 @default.
- W4386996839 cites W1797402756 @default.
- W4386996839 cites W1909177986 @default.
- W4386996839 cites W1964005033 @default.
- W4386996839 cites W1969808589 @default.
- W4386996839 cites W1970971339 @default.
- W4386996839 cites W1972051805 @default.
- W4386996839 cites W1992274329 @default.
- W4386996839 cites W2008245445 @default.
- W4386996839 cites W2008988352 @default.
- W4386996839 cites W2035343706 @default.
- W4386996839 cites W2053949852 @default.
- W4386996839 cites W2055433726 @default.
- W4386996839 cites W2058225286 @default.
- W4386996839 cites W2067165996 @default.
- W4386996839 cites W2086367502 @default.
- W4386996839 cites W2098891794 @default.
- W4386996839 cites W2101539565 @default.
- W4386996839 cites W2114235650 @default.
- W4386996839 cites W2117475731 @default.
- W4386996839 cites W2123842688 @default.
- W4386996839 cites W2248139588 @default.
- W4386996839 cites W2273973218 @default.
- W4386996839 cites W2282989227 @default.
- W4386996839 cites W2283420536 @default.
- W4386996839 cites W2328724398 @default.
- W4386996839 cites W2334138351 @default.
- W4386996839 cites W2334741322 @default.
- W4386996839 cites W2375460237 @default.
- W4386996839 cites W2401277190 @default.
- W4386996839 cites W2466014330 @default.
- W4386996839 cites W2471444529 @default.
- W4386996839 cites W2478596504 @default.
- W4386996839 cites W2522662070 @default.
- W4386996839 cites W2522967108 @default.
- W4386996839 cites W2560117663 @default.
- W4386996839 cites W2580222937 @default.
- W4386996839 cites W2768115885 @default.
- W4386996839 cites W2784218872 @default.
- W4386996839 cites W2790661765 @default.
- W4386996839 cites W2901390451 @default.
- W4386996839 cites W2944559840 @default.
- W4386996839 cites W2949397881 @default.
- W4386996839 cites W2952805186 @default.
- W4386996839 cites W2998747755 @default.
- W4386996839 cites W3011770161 @default.
- W4386996839 cites W3012532180 @default.
- W4386996839 cites W3012646782 @default.
- W4386996839 cites W3013225232 @default.
- W4386996839 cites W3103422819 @default.
- W4386996839 cites W3114550567 @default.
- W4386996839 cites W3204535357 @default.
- W4386996839 cites W3208890428 @default.
- W4386996839 cites W3211659049 @default.
- W4386996839 cites W3212791911 @default.
- W4386996839 cites W4210853074 @default.
- W4386996839 cites W4220869556 @default.
- W4386996839 cites W4221091269 @default.
- W4386996839 cites W4297902973 @default.
- W4386996839 cites W4298087762 @default.
- W4386996839 cites W4303954685 @default.
- W4386996839 cites W4313216073 @default.
- W4386996839 cites W4317733413 @default.
- W4386996839 cites W4323648030 @default.
- W4386996839 cites W4323811388 @default.
- W4386996839 cites W4324150361 @default.
- W4386996839 cites W4379876032 @default.
- W4386996839 cites W4386051872 @default.
- W4386996839 cites W631293117 @default.
- W4386996839 cites W76245527 @default.
- W4386996839 doi "https://doi.org/10.3390/molecules28196760" @default.
- W4386996839 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37836603" @default.
- W4386996839 hasPublicationYear "2023" @default.
- W4386996839 type Work @default.
- W4386996839 citedByCount "0" @default.
- W4386996839 crossrefType "journal-article" @default.
- W4386996839 hasAuthorship W4386996839A5009329347 @default.
- W4386996839 hasAuthorship W4386996839A5024925394 @default.
- W4386996839 hasAuthorship W4386996839A5025177419 @default.
- W4386996839 hasAuthorship W4386996839A5032278474 @default.
- W4386996839 hasAuthorship W4386996839A5041978951 @default.
- W4386996839 hasAuthorship W4386996839A5056143507 @default.